Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke

OBJECTIVE: We have shown that acute treatment with candesartan in an experimental model of stroke resulted in vascular protection and improved outcomes at 24 hours post-stroke, but the mechanisms are unknown. We now examine effects of candesartan on proangiogenic factors and 7-day outcomes using the...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kozak, Anna, Ergul, Adviye, El-Remessy, Azza B., Johnson, Maribeth H., Machado, Livia S., Elewa, Hazem F., Abdelsaid, Mohammed, Wiley, Daniel C., Fagan, Susan C.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2009
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716175/
https://ncbi.nlm.nih.gov/pubmed/19265050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.108.537225
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים